BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35648433)

  • 1. A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor β-caryophyllene.
    Baradaran Rahimi V; Askari VR
    Biofactors; 2022 Jul; 48(4):857-882. PubMed ID: 35648433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway.
    Bento AF; Marcon R; Dutra RC; Claudino RF; Cola M; Leite DF; Calixto JB
    Am J Pathol; 2011 Mar; 178(3):1153-66. PubMed ID: 21356367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors.
    Irrera N; D'Ascola A; Pallio G; Bitto A; Mazzon E; Mannino F; Squadrito V; Arcoraci V; Minutoli L; Campo GM; Avenoso A; Bongiorno EB; Vaccaro M; Squadrito F; Altavilla D
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31370242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effects of β-caryophyllene on LPS-induced primary microglia M
    Askari VR; Shafiee-Nick R
    Life Sci; 2019 Feb; 219():40-73. PubMed ID: 30620895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising neuroprotective effects of β-caryophyllene against LPS-induced oligodendrocyte toxicity: A mechanistic study.
    Askari VR; Shafiee-Nick R
    Biochem Pharmacol; 2019 Jan; 159():154-171. PubMed ID: 30529211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties.
    Fidyt K; Fiedorowicz A; Strządała L; Szumny A
    Cancer Med; 2016 Oct; 5(10):3007-3017. PubMed ID: 27696789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.
    Alberti TB; Barbosa WL; Vieira JL; Raposo NR; Dutra RC
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Effects of (
    Scandiffio R; Geddo F; Cottone E; Querio G; Antoniotti S; Gallo MP; Maffei ME; Bovolin P
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
    Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
    Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-Caryophyllene, a Plant-Derived CB2 Receptor Agonist, Protects SH-SY5Y Cells from Cadmium-Induced Toxicity.
    Mannino F; Pallio G; Imbesi C; Scarfone A; Puzzolo D; Micali A; Freni J; Squadrito F; Bitto A; Minutoli L; Irrera N
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
    Youssef DA; El-Fayoumi HM; Mahmoud MF
    Biomed Pharmacother; 2019 Feb; 110():145-154. PubMed ID: 30469079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.
    Cheng Y; Dong Z; Liu S
    Pharmacology; 2014; 94(1-2):1-12. PubMed ID: 25171128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors.
    Youssef DA; El-Fayoumi HM; Mahmoud MF
    Chem Biol Interact; 2019 Jan; 297():16-24. PubMed ID: 30343038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and independent manner.
    Meeran MFN; Laham F; Azimullah S; Sharma C; Al Kaabi AJ; Tariq S; Adeghate E; Goyal SN; Ojha S
    Free Radic Biol Med; 2021 May; 167():348-366. PubMed ID: 33588052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.
    Hashiesh HM; Meeran MFN; Sharma C; Sadek B; Kaabi JA; Ojha SK
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled volatile β-caryophyllene is incorporated into the aortic wall and attenuates nicotine-induced aorta degeneration via a CB2 receptor-dependent pathway.
    Kishi C; Higashihara M; Takemoto Y; Kamei M; Yoshioka Y; Matsumura S; Yamada K; Kobayashi T; Matahira Y; Moriyama T; Zaima N
    Biomed Pharmacother; 2022 Sep; 153():113423. PubMed ID: 36076543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.
    Jha NK; Sharma C; Hashiesh HM; Arunachalam S; Meeran MN; Javed H; Patil CR; Goyal SN; Ojha S
    Front Pharmacol; 2021; 12():590201. PubMed ID: 34054510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid.
    Hashiesh HM; Sharma C; Goyal SN; Sadek B; Jha NK; Kaabi JA; Ojha S
    Biomed Pharmacother; 2021 Aug; 140():111639. PubMed ID: 34091179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-caryophyllene is a dietary cannabinoid.
    Gertsch J; Leonti M; Raduner S; Racz I; Chen JZ; Xie XQ; Altmann KH; Karsak M; Zimmer A
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9099-104. PubMed ID: 18574142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise.
    Sharma C; Al Kaabi JM; Nurulain SM; Goyal SN; Kamal MA; Ojha S
    Curr Pharm Des; 2016; 22(21):3237-64. PubMed ID: 26965491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.